Unique Ingredient Identifier 660YQ98I10 is listed as a ingredient substance
| RN | 7447-40-7 |
| EC | 231-211-8 |
| NCIT | C47679 |
| RXCUI | 8591 |
| PUBCHEM | 4873 |
| MF | Cl.K |
| INCHI KEY | WCUXLLCKKVVCTQ-UHFFFAOYSA-M |
| SMILES | [Cl-].[K+] |
UNII 660YQ98I10 POTASSIUM CHLORIDE is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| AN,INFILTRATION | INJECTION | 0.03 % |
| CAUDAL BLOCK | INJECTION | 0.03 % |
| EPIDURAL | INJECTION | 0.03 % |
| INHALATION | POWDER | 0.18 MG |
| INTRAOCULAR | SOLUTION | 0.075 % |
| INTRAVENOUS | INJECTION | NA |
| INTRAVENOUS | SOLUTION, INJECTION | 0.44 % |
| INTRAVITREAL | SUSPENSION, INJECTION | 0.075 % |
| IRRIGATION | SOLUTION | 0.037 % |
| IV(INFUSION) | INJECTION | NA |
| NASAL | POWDER, FOR INHALATION | NA |
| NERVE BLOCK | INJECTION | 0.03 % |
| OPHTHALMIC | DROPS | 0.03 % |
| OPHTHALMIC | POWDER, FOR SOLUTION | 0.075 % |
| OPHTHALMIC | SOLUTION | 0.3 MG/1ML |
| OPHTHALMIC | SOLUTION | 0.23 % |
| OPHTHALMIC | SOLUTION, DROPS | 0.14 % |
| OPHTHALMIC | SUSPENSION | NA |
| ORAL | CAPSULE | 62 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 0.4 MG |
| ORAL | SUSPENSION | NA |
| ORAL | TABLET | 40 MG |
| ORAL | TABLET, EXTENDED RELEASE | 9.9 MG |